Latest Breaking News On - Magellan specialty health to evolent - Page 1 : comparemela.com

Centene pulls in $45 million in profit in Q4

Centene pulls in $45 million in profit in Q4
healthcarefinancenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcarefinancenews.com Daily Mail and Mail on Sunday newspapers.

United statesMedicaid servicesMagellan specialty healthMagellan specialty health to evolentCenters for medicarePrime therapeuticsEvolent healthSpecialty health

Centene to lay off 3% of total workforce in rightsizing of cost structure

Centene to lay off 3% of total workforce in rightsizing of cost structure
healthcarefinancenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcarefinancenews.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew asherMagellan specialty healthMagellan specialty health to evolentPartd star ratingsChief financial officer andrew asherMedicare advantagePrime therapeuticsEvolent healthSpecialty health

Centene down $213 million in Q4 despite revenue gains

Despite a 9% increase in revenue in the fourth quarter, healthcare payer Centene reported a $213 million net earnings loss during that period, falling short of Wall Street predictions, the organization revealed this week. Centene posted $1.2 billion in profit for the year, down from the $1.3 billion it logged the previous year. Revenue, however, jumped from $126 billion to

Centers for medicareMagellan healthMagellan specialty healthMagellan specialty health to evolentMedicaid servicesWall streetEvolent healthAdjusted earnings per share

Walgreens sells AmerisourceBergen stock • UChicago putting lawyers by the bedside

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

United statesUniversity of chicagoUniversity of illinoisWest virginiaAkram boutrosSelwyn rogers jrMostafa kamalAllison arwadyVivek murthyKwame raoulAmy guthStephanie willdingMaurice smithThomas stoegerCory chaplinUnited states court

Centene sells Magellan RX to Prime Therapeutics for $1 35B

This sale advances Centene's value creation initiative, which aims to increase profits through divestitures and leadership changes.

Mostafa kamalKen paulusMagellan healthMagellan specialty health to evolentVistria groupPrime therapeuticsGeneral atlanticNautic partnersMagellan specialty healthEvolent healthPolitan capital managementPrime therapeuticBlue shieldTherapeutics president